ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death
Author(s): Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, Kronke M, Adam D
Source: JOURNAL OF EXPERIMENTAL MEDICINE    Volume: 192    Issue: 5    Pages: 601-611    Published: SEP 4 2000  
Times Cited: 83     References: 43     
Abstract: Tumor necrosis factor (TNF) signals cell death and simultaneously induces generation of ceramide. To evaluate the contribution of ceramide to TNF-dependent cell death, we generated clones of the TNF-sensitive cell line L929 that constitutively overexpress human acid ceramidase (AC). Ceramidase, in concert with sphingosine kinase, metabolizes ceramide to sphingosine-l-phosphate (SPP), an inducer of proliferation. In response to TNF, parental L929 cells display a significant increase in intracellular ceramide correlated with an "atypical apoptosis" characterized by membrane blebbing, DNA fragmentation and degradation of poly(ADP-ribose) polymerase despite a lack of caspase activity. These features are strongly reduced or absent in AC-overexpressing cells. Pharmacological suppression of AC with N-oleoylethanolamine restored the accumulation of intracellular ceramide as well as the sensitivity of the transfectants to TNF, implying that an enhanced metabolization of intracellular ceramide by AC shifts the balance between intracellular ceramide and SPP levels towards cell survival. Correspondingly, inhibition of ceramide production by acid sphingomyelinase also increased survival of TNF-treated L929 cells.
Document Type: Article
Language: English
Reprint Address: Adam, D (reprint author), Univ Kiel, Inst Immunol, Michaelisstr 5, D-24105 Kiel, Germany
Addresses:
1. Univ Kiel, Inst Immunol, D-24105 Kiel, Germany
2. Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany
Publisher: ROCKEFELLER UNIV PRESS, 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
Subject Category: Immunology; Medicine, Research & Experimental
IDS Number: 353FW
ISSN: 0022-1007
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo